Research collaboration to validate plant-derived antifungal compounds effective against Fusarium fungi, which cause significant yield losses in faba bean crops. Building on prior in vitro screening with Ethiopian plant extracts, this project aims to isolate, characterize, and evaluate bioactive compounds through greenhouse trials to develop a marketable crop protection product.
This research initiative focuses on validating the antifungal activity of plant-derived metabolites against Fusarium soil fungi, a major pathogen responsible for faba bean root wilt in Ethiopia. Faba bean is a critical staple food crop in the region, and Fusarium-related diseases can reduce productivity by up to 50%. Previous in vitro screening conducted in collaboration with the Ethiopian Institute of Agricultural Research (EIAR) identified active plant extracts and compounds with promising antifungal properties. The goal of this project is to move beyond laboratory validation toward developing a practical, marketable crop protection product that can help safeguard food security for smallholder farmers.
Research approach:
Target application:
The research is currently at an early-to-mid stage of development. Prior in vitro screening has successfully identified active extracts and compounds, providing a foundation for further validation. The next critical steps involve greenhouse (in vivo) evaluation to confirm efficacy under more realistic growing conditions. The project explicitly seeks cooperation among funding and research organizations to advance the work toward a commercially viable product. Successful completion of greenhouse trials would represent a significant step toward field validation and eventual product development.
Addis Ababa University is a comprehensive public research university in Ethiopia’s capital, serving a large and diverse student body across broad academic and professional programs. Industry engagement is enabled by co-located laboratories, innovation hubs and incubators, contract research mechanisms, and an engineering institute that partners on prototyping and product development. Integration with major teaching hospitals supports clinical studies and translational pathways. Research is backed by competitive national funding and international sponsors and foundations. A dedicated technology transfer office manages IP, licensing, and startup support, with industry liaison staff to streamline collaboration.